Arcus Biosciences - Stock Price History | RCUS
Historical daily share price chart and data for Arcus Biosciences since 2022 adjusted for splits. The latest closing stock price for Arcus Biosciences as of August 15, 2022 is 28.00.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
- The all-time high Arcus Biosciences stock closing price was 48.47 on November 23, 2021.
- The Arcus Biosciences 52-week high stock price is 49.10, which is 75.4% above the current share price.
- The Arcus Biosciences 52-week low stock price is 16.74, which is 40.2% below the current share price.
- The average Arcus Biosciences stock price for the last 52 weeks is 31.77.
|Arcus Biosciences Historical Annual Stock Price Data
||Average Stock Price
||Annual % Change
||Medical - Biomedical and Genetics
Arcus Biosciences is a biopharmaceutical company. It focused on creating innovative cancer immunotherapies. The company's product portfolio includes AB928, AB122, AB154 and AB680. AB928 which is in its final phase is a potent and selective dual antagonist of the adenosine receptors. AB122 which is in its Phase1 is a monoclonal antibody which potently and selectively blocks a protein called PD-1. AB154 is a monoclonal antibody which potently and selectively blocks a novel immune checkpoint called TIGIT. AB680, which is in its Phase1 is a potent and selective inhibitor of CD73, the enzyme responsible for the extracellular production of adenosine within the tumor micro-environment. Arcus Biosciences is based in Hayward, CA.